Gland Pharma P/E Ratio

GLAND • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
33.19
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 33.19
Current Price ₹1728.50
EPS (TTM) ₹42.40
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 41.09
Historical Range 30.45 - 64.12
Percentile 33.3%

Sector Context

Sector Average 47.6
Sector Median 25.5
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹51.42
Sept 2025 ₹11.15
Mar 2025 ₹11.32

Key P/E Ratio Insights for Gland Pharma

  • Stock appears overvalued with PE of 33.19, suggesting caution for new investments
  • Trading at discount to sector average PE of 47.6

P/E Ratio Historical Trend for Gland Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 35.2 51.42 ₹1810.10 NSE High
2024 44.59 42.76 ₹1906.55 NSE High
2023 39.4 40.0 ₹1575.90 NSE High
2022 64.12 60.06 ₹3851.30 NSE High
2021 32.76 72.33 ₹2369.70 NSE High
2020 30.45 59.76 ₹1819.55 NSE High

Sector P/E Ratio Comparison

Comparing Gland Pharma with other companies in Healthcare sector
Sector Average
47.6
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low